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Objective: Multiple sclerosis (MS) is a neurological disease with a substantial genetic component and immune-mediated
neurodegeneration. Patients with MS show structural brain differences relative to individuals without MS, including smaller
regional volumes and alterations in white matter (WM) microstructure. Whether genetic risk for MS is associated with brain
structure during early neurodevelopment remains unclear. In this study, we explore the association between MS polygenic
risk scores (PRS) and brain imaging outcomes from a large, population-based pediatric sample to gain insight into the under-
lying neurobiology of MS.
Methods: We included 8- to 12-year-old genotyped participants from the Generation R Study in whom T1-weighted
volumetric (n = 1,136) and/or diffusion tensor imaging (n = 1,088) had been collected. PRS for MS were calculated
based on a large genome-wide association study of MS (n = 41,505) and were regressed on regional volumes, global
and tract-specific fractional anisotropy (FA), and global mean diffusivity using linear regression.
Results: No associations were observed for the regional volumes. We observed a positive association between the MS
PRS and global FA (β = 0.098, standard error [SE] = 0.030, p = 1.08 × 10−3). Tract-specific analyses showed higher FA
and lower radial diffusivity in several tracts. We replicated our findings in an independent sample of children (n = 186)
who were scanned in an earlier phase (global FA; β = 0.189, SE = 0.072, p = 9.40 × 10−3).
Interpretation: This is the first study to show that greater genetic predisposition for MS is associated with higher
global brain WM FA at an early age in the general population. Our results suggest a preadolescent time window within
neurodevelopment in which MS risk variants act upon the brain.
ANN NEUROL 2020;00:1–14
Multiple sclerosis (MS) is a severe neurological disor-der caused by demyelination in the central nervous
system (CNS).1 In addition to distinctive demyelinating
lesions, several extensive brain differences have been
reported in adult and pediatric MS patients. For example,
brain imaging studies have shown atrophy of gray matter
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(GM), particularly in the thalamus, hippocampus, and
other subcortical structures,2,3 as well as alterations in the
microstructure of normal-appearing white matter (WM).2,4
Studies in children with a diagnosis of MS have shown
reduced total and regional brain volumes at first presentation
of symptoms compared to their healthy peers,5 which raises
the question of whether neurodevelopmental differences are
present before the clinical presentation of MS.
Genetic factors have been shown to contribute con-
siderably to MS pathophysiology, as is evidenced by an
increased relative risk (9.5–116.7 fold) of MS in individ-
uals with an affected first-degree family member and heri-
tability estimates of approximately 30%.6,7 In addition,
previous work has shown evidence of WM lesions in
asymptomatic relatives of adult MS patients.8 A recent
genome-wide association study (GWAS) has identified
233 genome-wide significant genetic variants (single
nucleotide polymorphisms [SNPs]), mainly with immuno-
logical functions, associated with the risk of MS.9 This
work demonstrated that the risk of MS is highly polygenic,
with a large number of common genetic variants each con-
tributing a small effect to the overall MS disease risk.
One technique used to quantify the effect of com-
bined genetic risk of multiple common risk variants across
the genome is the use of polygenic risk scores (PRS).10,11
An increased PRS of MS has shown to be associated with a
higher risk of MS and an increased susceptibility to pediatric-
onset MS.12,13 In addition, PRS can be used to explore
whether a high genetic risk leads to a higher degree of disease-
related alterations, such as in brain imaging measures. Large
population-based imaging studies in adults from the general
population show that smaller GM volume is related to higher
genetic risk for MS.14 Further, higher fractional anisotropy
(FA) and lower mean diffusivity (MD) were observed in sev-
eral WM tracts for a PRS for MS, as well as numerous indi-
vidual genetic risk variants, although not passing statistical
significance testing correction.14,15
Importantly, most previous studies investigating the
PRS for MS focused only on those variants that passed
genome-wide significance (except for Brown et al15), omit-
ting other common risk variants that likely also contribute
substantially to the risk of MS.9 Furthermore, associations
with brain imaging outcomes have not been studied in
younger populations, which may provide valuable insight
into the link between genetic risk of MS and neuro-
development during childhood.
Within this context, it is our goal to study the asso-
ciation between genetic risk for MS using PRS and brain
magnetic resonance imaging (MRI) that indexes neuro-
development in school-age children, including volumetric
and microstructural brain measures. As the window of
opportunity for prevention and treatment of MS may exist
during childhood, we aimed to assess whether genetic risk
may index brain alterations earlier than has been expected.
Subjects and Methods
Study Sample
This study was conducted using data from the Generation R Study,
a longitudinal population-based birth cohort (n = 9,749) designed to
examine different facets of pediatric development.16 Between March
2013 and November 2015, 3,992 participants aged 8 to 12 years vis-
ited a study-dedicated research center for an MRI scan.17 The pre-
sent study included unrelated participants of European ancestry with
usable MRI and genotype data (Fig 1). Children with perinatal WM
abnormalities, as assessed by a neuroradiologist, were excluded. None
of the included participants showed other WM abnormalities such as
radiologically isolated syndrome.
To replicate our findings, we identified a sample of partici-
pants included from an earlier phase of the Generation R imaging
study who did not participate in the current study (n = 186; for
study details, see White et al18 and Muetzel et al19). The Genera-
tion R Study protocol was approved by the Medical Ethical Com-
mittee of the Erasmus Medical Center; the study was conducted
according to the Declaration of Helsinki. Written informed consent
was obtained from the children’s parents or legal representatives.
Genotype Data
Genotype data were obtained from cord blood at birth or from
venipuncture during a visit to the research center using either a
610K or 660K SNP array (Illumina, San Diego, CA). Sample
collection and genotype calling procedures have been described
elsewhere.20 Information about additional quality control proce-
dures of the genotype data, genotype imputation, and calculation
of principal components has been reported in a previous study.21
In short, we included participants of European ancestry based
upon the first 4 principal components inside the range of the
HapMap Phase II Northwestern European founder population
and used the 1,000 Genomes (phase I version 3) imputed geno-
type data for the calculation of our PRS.22,23
Polygenic Scores
We used a recent large discovery GWAS of MS in 41,505 indi-
viduals (14,802 cases and 26,703 controls)9 to compute a
weighted PRS based on imputed genotype data. Results from the
MS discovery GWAS were obtained via the International Multi-
ple Sclerosis Genetics Consortium (IMSGC; http://imsgc.net/
publications/). PRS was calculated using PRSice 2,24 an R-script
that carries out PRS calculation across several p value thresholds
(PTs) using PLINK (v1.9).
25,26
We removed high linkage disequilibrium regions (r2 < 0.10,
kB window = 250kB) by using the Generation R European sample
as a reference. After this, we used several PTs for inclusion of SNPs
in the computation of the PRS (PT < 0.001, 0.005, 0.01, 0.05, 0.1,
0.5, 1). We also calculated a PRS including only SNPs that reached
genome-wide significance (PT < 5 × 10
−8) in the final meta-analysis
from the IMSGC (n = 115,803; 47,429 cases and 68,374
controls).9
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Given the strong effect of variants located in the major his-
tocompatibility complex (MHC), we calculated 2 sets of PRS,
1 including all available SNPs and another excluding SNPs from
the MHC region. For characterization of HLA-DRB1*15:01,
rs3135388 was used as the tag SNP.27
The number of SNPs included in a given PRS at different
PTs is shown in Table 1. The distribution of the calculated PRS
across the whole study population can be found in Figure 2. The
PRS were comparable across gender and independent of age at
scan (see Fig 2).
Brain MRI
Imaging of the brain was performed on a single study-dedicated
3T MR750w Discovery scanner (General Electric, Milwaukee,
WI). Both high-resolution structural MRI and diffusion-
weighted images were collected. A detailed description of the
scan protocol, imaging procedures, and subsequent processing of
the imaging data can be found in earlier work from our study
group.17,19,28
For analyses involving volumetric brain measures, we used
T1-weighted images. Regions of interest (ROI) were defined
(including thalamus, hippocampus, total subcortical volume,
total GM, and total WM) using the FreeSurfer software package
(v6.0)29 and the Desikan–Killiany atlas, which contains 34 corti-
cal parcels per hemisphere.30 For diffusion tensor imaging
(DTI) analyses, we used the functional MRI of the Brain’s Soft-
ware Library (FMRIB FSL) and the Camino Diffusion MRI
Toolkit to preprocess the data.31,32 The AutoPtx probabilistic
tractography plugin was then used to identify 12 major WM
tracts.33 Within these tracts, diffusion characteristics were used
to quantify average FA and MD. To model a single latent factor
of global FA and MD, representing global indicators of WM
microstructure in the brain, these 12 tracts were submitted to
confirmatory factor analysis (CFA) using the lavaan R pack-
age.19,28 The WM tracts included in the CFA model, the stan-
dardized loading factors, and the fit indices of the global factors
for FA and MD resulting from the model can be found in Sup-
plementary Table 1.
FIGURE 1: Flowchart describing the selection process of the study. DTI = diffusion tensor imaging; QC = quality control;
T1-W = T1-weighted.
TABLE 1. Total Number of SNPs in the Different PRS
PRS PT < 5 × 10
−8 PT < 0.001 PT < 0.005 PT < 0.01 PT < 0.05 PT < 0.1 PT < 0.5 PT < 1
All available variants, n 198 1,854 4,963 7,920 24,593 40,615 118,343 161,270
Excluding MHC
variants, n
191 1,704 4,800 7,751 24,399 40,406 118,101 161,012
Amount of single nucleotide polymorphisms (SNPs) included in the polygenic risk score (PRS) at each p value threshold (PT).
MHC = major histocompatibility complex.
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The participants in the replication sample were scanned on a
3T MR750 Discovery MRI scanner between September 2009 and
February 2012 and were between 6 to 10 years old. During the
brain imaging session, both structural and DTI images were
acquired. The structural brain data images were segmented using
Freesurfer (v5.3),34 and DTI data were processed using the FMRIB
FSL and the Camino Diffusion MRI Toolkit.19
Nonverbal IQ
Nonverbal IQ data were studied to assess the association between
the MS PRS and cognitive functioning. Nonverbal IQ was
assessed at the age of 6 years in around 6,000 participants using
2 subsets of a nonverbal IQ test: Snijders-Oomen Nonverbal
Intelligence Test–Revised (SON-R 2.5–7; www.testresearch.nl).
The subsets for Mosaics (spatial visualization abilities) and
FIGURE 2: Descriptive characteristics of the polygenic risk scores at the different p value thresholds (PTs) across the whole study
population (n = 1,259). (A) Density distribution of the polygenic risk scores across the whole study population at the different
PTs. (B) Distribution of the polygenic risk scores at the different PTs across gender. (C) Height of the polygenic risk scores across
the age span of our study at the different PTs.
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Categories (abstract reasoning abilities) were used to compute
age- and sex-normalized nonverbal IQ scores.
To investigate a possible relationship between the MS
PRS, WM microstructure, and cognitive functioning, we per-
formed an additional supplementary analysis between the
PRS and nonverbal IQ in participants who had DTI data
available.
Statistical Analysis
All analyses were performed using the R statistical software
package (v3.5.1).25 Before running each model, all variables of
interest were checked for normality. We applied t tests to assess
the difference in PRS for MS (PT < 1) and descriptive charac-
teristics (gender and level of maternal education) with the par-
ticipants that did not participate in the volumetric and/or DTI
scanning.
For the volumetric brain analyses, the PRS of MS across
different thresholds were regressed on total brain volume (TBV).
For DTI, the PRS of MS with different thresholds were regressed
on global FA and MD. In secondary analyses, the PRS based on
the PT that showed the strongest association with the global out-
come in the primary analyses was regressed on the individual
regional metrics (ie, ROI volumes for the volumetric analyses and
the different WM tracts for DTI analyses). In WM tracts that
showed evidence of association with the PRS, we ran post hoc
analyses testing the associations between the PRS of MS and
radial and axial diffusivity (RD and AD, respectively) to gain fur-
ther insight into the diffusion profile that contributes to differ-
ences in FA or MD.
All analyses were adjusted for age at scan, sex, and the first
10 genetic principal components, the latter to adjust for residual
effects due to population substructure. Volumetric analyses for
specific brain regions were adjusted for total intracranial volume
to mitigate the possible confounding effects of head size. In the
DTI analyses, we performed sensitivity analyses in the WM
tracts correcting for the global diffusion factor to explore whether
the PRS associations are primarily global or tract specific. To cor-
rect for multiple testing, we used false discovery rate (FDR)35 on
the total number of statistical tests for each risk score, PT, and
global, tract-specific, and regional measures. FDR-corrected sig-
nificance threshold was applied separately for DTI and morphol-
ogy. This translated to an uncorrected PT of 0.013 for the DTI
analyses and 0.004 for the volumetric analyses.
Lastly, we performed linear regression analyses using
inverse probability-of-censoring weights (IPCWs) to account
for potential differences between the study sample and the
Generation R base sample.36 In short, descriptive characteristics
that differed between participants included in the MRI study
and those in the Generation R base sample (excluding those
who participated in the present study) were fitted as covariates
into a logistic regression model in the Generation R base sam-
ple to estimate a pseudopopulation with a conditional probabil-
ity and weight for each subject. These weights were used in
the study sample regression analyses to account for possible
induced selection bias.37
Results
Sample Selection and Information
T1-weighted structural MRI scans were completed in
3,850 participants, and DTI scans were available in
3,786 participants. A total of 3,186 participants had eligi-
ble T1-weighted scans after excluding images that were
collected using different acquisition parameters (n = 22),
those with poor image quality (n = 620), and images
including major incidental findings (n = 22). Scanner
software was upgraded during the study period, which
did not affect T1-weighted volumetric data. However,
DTI data were influenced and participants were excluded
based on scanner software version. A total of 3,050 partici-
pants were found to have eligible DTI scans after excluding
TABLE 2. Demographic and Educational Information about the Study Samples
T1-W Volumetric MRI,
n = 1,136 DTI, n = 1,088 p
Female, n (%) 561 (49.4) 536 (49.2) 0.99
Age at MRI scan, median (IQR), yr 9.95 (9.76–10.31) 9.96 (9.78–10.36) 0.49
Level of maternal education, n (%)
Low-middle 348 (30.6) 328 (30.1) 0.84
High 767 (67.5) 739 (67.9) 0.87
Unknown 21 (1.8) 21 (1.9) 1.00
Presence of maternal MS, n (%) 6/964 (0.6) 4/920 (0.4) 0.81
Presence of paternal MS, n (%) 2/779 (0.3) 4/758 (0.5) 0.90
DTI = diffusion tensor imaging; IQR = interquartile range; MRI = magnetic resonance imaging; MS = multiple sclerosis; T1-W = T1-weighted.
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participants with poor image quality (n = 447), different
version of scanner software (n = 276), and incidental
findings (n = 13). Genotype data were available in
2,040 of the participants with T1-weighted scans and
in 1,903 of the participants with eligible DTI data. Subse-
quent selection on European ancestry, relatedness, and
genotype quality resulted in 1,136 participants eligible for
volumetric analyses and 1,088 participants eligible for DTI
analyses (see Fig 1).
Participants included in the volumetric analyses had
a median age of 9.95 years (interquartile range [IQR] =
9.76–10.31), and sex was evenly distributed (49.4% female;
FIGURE 3: Distribution of the T1-weighted volumetric outcomes in our study population (n = 1,136). (A) Distribution of the
volumetric outcomes across gender (in mm3). (B) Size of our volumetric outcomes across the age span of our study
population (in mm3).
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Table 2). The distribution of the different T1-weighted vol-
umes between gender and across the age span is shown in
Figure 3. No difference was found in mean PRS of MS
(p = 0.54) or in gender distribution (p = 0.57) compared to
participants who did not participate in the volumetric MRI
scanning (n = 1,694). However, we observed higher levels of
maternal education in the participants eligible for the
T1-weighted MRI analyses (p < 0.01). The median age in the
participants included for the DTI analyses was 9.96 years
(IQR = 9.78–10.36), with an even distribution of sex (49.2%
female; see Table 2). Figure 4 shows the distribution of global
FA andMD between the genders and across the different ages.
There were no differences in mean PRS for MS (p = 0.96) and
gender (p = 0.66) compared to genotyped participants of
European ancestry who did not participate in the DTI scan-
ning (n = 1,742). In the sample eligible for the DTI analyses,
we again had a relative overrepresentation of high maternal
education (p < 0.01).
T1-Weighted Volumes
Figure 5 shows the PRS–TBV associations across different
thresholds and the explained variance in TBV by the PRS.
Several different thresholds showed positive associations
with TBV (β = 0.055, standard error [SE] = 0.025,
ΔR2= 0.0030, p = 0.03). However, this was not significant
after multiple testing correction. Supplementary Table 2
shows the full regression results of the PRS on TBV.
The PRS PT with the strongest association with
TBV was regressed on different subcortical volumes to test
for specific regional associations (PT < 0.01), but none
were found to be significant. Supplementary Table 3
shows the regression results of the PRS for MS on the dif-
ferent volumes.
WM Microstructure
The PRS for MS showed significant positive associations
with global FA across different PT (Fig 6). The PRS with
a PT < 0.01 had the strongest association with global FA
(β = 0.098, SE = 0.030, ΔR2= 0.0095, p = 1.08 × 10−3;
Supplementary Table 4). Visual representations of the signifi-
cant associations with global FA are shown in Figure 6.
The PRS showed mainly negative associations with
MD (β = −0.050, SE = 0.029, ΔR2= 0.0025, p = 0.09),
but these were not significant (see Fig 6, Supplementary
Table 5). The analyses using PRS of MS excluding the
HLA-DRB1*15:01 tag variant rs3135388 and the MHC
FIGURE 4: Distribution of global fractional anisotropy (FA) and mean diffusivity (MD) in our study population (n = 1,088).
(A) Distribution of our diffusion outcomes across gender. (B) Development of our diffusion outcomes across the age span.
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region are shown in Supplementary Tables 6 to 10. When
excluding rs3135388, we observed an attenuation of the
observed associations of the PRS; however, they remained
statistically significant. We observed a larger decrease in the
strength of the association after excluding the total MHC
region, but the directions of the effect remained consistent
(positive on global FA and negative on global MD).
Tract-Specific Analyses
To investigate tract-specific associations between MS PRS
and WM, the PRS with the strongest association with global
FA (PT < 0.01) was regressed on individual WM tracts.
Because the PRS showed no associations with global MD, we
did not perform tract-specific analyses for MD. The PRS
showed positive associations with FA in 6 tracts: the superior
longitudinal fasciculus (SLF left: β = 0.104, SE = 0.030,
ΔR2 = 0.0107, p = 5.90 × 10−4; SLF right: β = 0.080,
SE = 0.030, ΔR2= 0.0064, p = 8.17 × 10−3), the forceps
minor (FMI; β = 0.091, SE = 0.030, ΔR2= 0.0082,
p = 2.75 × 10−3), the cingulate gyrus part of the cingulum
(right: β = 0.069, SE = 0.029, ΔR2= 0.0047, p = 0.02),
and the corticospinal tract (CST left: β = 0.103, SE = 0.030,
ΔR2= 0.0104, p = 6.96 × 10−4; CST right: β = 0.072, SE =
0.030, ΔR2= 0.0052, p = 0.02; Table 3, Fig 7). Exclusion of
rs3135388 and the MHC region showed similar attenuations
of the tract-specific associations (see Fig 7).
In the significant tracts, the PRS of MS (PT < 0.01)
was also regressed on RD and AD to explore the effect of
the risk variants further (Supplementary Table 11). No sig-
nificant associations were found for AD. For RD, the PRS
FIGURE 5: Explained variance in total brain volume (TBV) by the different polygenic risk scores (PRS). (A) The y-axis represents
the increase in explained variance (R2) by including the PRS of multiple sclerosis in the model. The shades of the bars
represent the different p value thresholds (PTs) for inclusion of single nucleotide polymorphisms (SNPs) in the PRS. (B) The y-axis
represents the standardized regression coefficients of the different PRS on TBV, corrected for age, sex, and 10 genetic principal
components.
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had significant negative associations in the FMI (β =
−0.078, SE = 0.030, ΔR2= 0.0061, p = 9.92 × 10−3) and
CST (left: β = −0.097, SE = 0.030, ΔR2= 0.0094,
p = 1.28 × 10−3; right: β = −0.081, SE = 0.030,
ΔR2= 0.0066, p = 7.07 × 10−3). When also correcting for
global FA, none of the tract-specific FA associations were
FIGURE 6: Explained variance in global fractional anisotropy (FA) and global mean diffusivity (MD) by the different polygenic risk scores
(PRS). (A) The y-axis represents the increase in explained variance (R2) by including the PRS of MS in the model. The shades of the bars
represent the different p value thresholds (PTs) for inclusion of SNPs in the PRS. (B) The y-axis represents the standardized regression
coefficients of the different PRS on global FA and global MD, corrected for age, sex, and 10 genetic principal components. (C) Scatter
plots of the significant associations between ourMSPRS andglobal FA after correcting formultiple testing.
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significant (mean attenuation [%] = −0.37, range = −0.98
to 0.27).
Replication Sample
We tested our DTI findings for replication in an indepen-
dent sample of 186 participants (median age = 8.5 years).
Similar significant positive associations of the PRS of MS
with global FA were observed (PT < 0.005: β = 0.189,
SE = 0.072, ΔR2= 0.0330, p = 9.40 × 10−3). We also
found significant negative associations with global MD
(PT < 0.005: β = −0.243, SE = 0.072, ΔR2= 0.0546,
p = 9.21 × 10−4; Supplementary Table 12).
Tract-specific significant positive associations with FA
were found in the forceps major, inferior longitudinal fas-
ciculus, and the left CST (Supplementary Table 13, see
Fig 7). Again, these associations attenuated to statistical
nonsignificance after correction for global FA (mean attenu-
ation [%] = −1.10, range = −3.40 to 1.05).
Inverse Probability-of-Censoring Weighting
To account for the relative overrepresentation of high
maternal education in our DTI sample, we performed an
additional analysis using IPCW based on maternal educa-
tion. Although most of the effect estimates attenuated, the
associations between the PRS for MS and global FA
remained significant (Supplementary Tables 14–16).
Associations of MS PRS with Nonverbal IQ
To investigate the effect of genetic risk for MS on cogni-
tive functioning, we tested associations between the PRS
and nonverbal IQ using a sample of 2,060 Caucasian par-
ticipants (mean age at IQ assessment = 6.0 years, 50.3%
female). The MS PRS was positively associated with
TABLE 3. Regression Results of the Polygenic Risk
Score (PT < 0.01) on the Fractional Anisotropy of
12White-Matter Tracts
Fractional Anisotropy, PT < 0.01
Tract β SE ΔR2 p
UNC L 0.048 0.030 0.0023 0.11
UNC R 0.048 0.030 0.0023 0.11
CGC L 0.032 0.029 0.0010 0.27
CGC R 0.069 0.029 0.0047 0.02b
SLF L 0.104 0.030 0.0107 5.90 × 10−4a,d
SLF R 0.080 0.030 0.0064 8.17 × 10−3a,c
FMI 0.091 0.030 0.0082 2.75 × 10−3a,c
FMA 0.033 0.030 0.0011 0.28
ILF L 0.033 0.030 0.0011 0.27
ILF R 0.013 0.030 0.0002 0.67
CST L 0.103 0.030 0.0104 6.96 × 10−4a,d
CST R 0.072 0.030 0.0052 0.02b
Regression results are corrected for age, sex, and 10 genetic principal
components.
aSignificant p values after multiple testing correction (false discovery
rate: p < 0.013).
bUnrounded p < 0.05.
cUnrounded p < 0.01.
dUnrounded p < 0.001.
CGC = cingulate gyrus part of cingulum; CST = corticospinal tract;
FMA = forceps major; FMI = forceps minor; ILF = inferior longitudinal
fasciculus; L = left; R = right; SE = standard error; SLF = superior longi-
tudinal fasciculus; UNC = uncinate fasciculus.
FIGURE 7: Effects of the polygenic risk score (p value threshold [PT] < 0.01 in our main study sample and PT < 0.005 in our replication
sample) on the fractional anisotropy (FA) of 12 white-matter tracts, including effects when removing rs3135388 and the major
histocompatibility complex (MHC) region. Effects are standardized beta coefficients, corrected for age, sex, and 10 genetic principal
components. An increased beta is represented by an increasingly yellow white matter tract; top to bottom: sagittal view, axial view, and
coronal view. A = anterior; CGC = cingulate gyrus part of cingulum; CST = corticospinal tract; FMA = forceps major; FMI = forceps minor;
ILF= inferior longitudinal fasciculus; L = left; P =posterior; R= right; SLF= superior longitudinal fasciculus; UNC=uncinate fasciculus.
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nonverbal IQ across all thresholds (β = 0.057, SE = 0.022,
ΔR2= 0.0031, p = 0.01; Supplementary Table 17); how-
ever, these results did not remain significant following
multiple testing correction. In addition, we performed an
analysis using IPCW to account for possible differences in
maternal education between the IQ study sample and the
Generation R base sample. This showed the same consis-
tent results (Supplementary Table 18).
In the participants who had DTI data available, in
addition to the MS PRS and nonverbal IQ (n = 942;
mean age at IQ assessment = 6.0 years, 49.0% female),
the MS PRS was not significantly associated with nonver-
bal IQ across all thresholds (β = 0.052, SE = 0.033,
ΔR2= 0.0026, p = 0.12; Supplementary Table 19).
Discussion
We found evidence for a relationship between the combi-
nation of common genetic variants for MS and brain
imaging phenotypes. Namely, we found a positive rela-
tionship between the MS PRS and WM microstructure in
school-age children from the general population. The MS
PRS explained approximately 1% of the variance in global
FA. Although the effects were small, we were able to repli-
cate our findings in an independent sample of children in
the Generation R Study who were scanned in an earlier
wave and with a different MRI scanner. Effect directions
in this sample were consistent although accompanied by
increased beta coefficients compared to our main study
sample, probably due to the smaller sample size having a
greater chance of inflating the effect sizes.
Focusing on the specific WM tracts, we found sig-
nificant positive associations with FA in the SLF, FMI,
and CST. However, after correction for global FA, these
relationships were no longer significant. This finding sug-
gests a global effect of genetic MS risk on WM micro-
structure, instead of tract-specific effects. We found no
association between the genetic risk for MS and the global
or regional T1-weighted volumetric MRI measures.
In addition, we observed a positive, albeit nonsignifi-
cant, association between genetic risk for MS and nonver-
bal IQ, with the PRS explaining approximately 0.3% of
its variance. This may be due to a higher global FA in
children with higher genetic risk for MS.19 However, the
temporal dynamics of our study (ie, global FA being mea-
sured relatively far after nonverbal IQ) stop us from carry-
ing out a proper mediation analysis, which could provide
insight into WM microstructure mediating the MS PRS
and nonverbal IQ association.
Previous studies in MS patients report lower FA and
higher diffusivity in several WM tracts of the CNS in
adults and children.2,4 Our findings in a population-based
study of children showed the opposite effect, providing an
indication about the way the genetics of MS may influ-
ence WM and its components during neurodevelopment.
Because FA and RD are associated with myelin integrity
and myelination status of WM, our results may indicate a
higher myelin integrity or different myelin status in chil-
dren with a higher genetic risk for MS.38,39 However,
myelin is not the only factor determining FA. Branching
and coherence of neuronal fibers also influence the degree
of FA.40 A high number of crossing and branching fibers
may reduce FA through an increased diffusion in multiple
directions along the orientation of the fibers. With the
degree of neuronal branching decreasing, the FA increases
as the diffusivity along secondary and tertiary directions
reduces (ie, RD).41 Hence, another explanation for the
observed increased FA in children with a higher PRS
accompanied by a lowered RD may be a significant
decrease in the neuronal branching of several WM tracts.
In this way, genetic risk of MS may affect WM matura-
tion and disrupt neurodevelopment at the early age of our
study sample. However, this mechanism would not be
supported by the positive association we report between
the MS PRS and nonverbal IQ. Future studies investigat-
ing the mechanisms involved in genetic MS risk, WM
microstructure, and cognitive functioning would provide
valuable insights. For example, an analysis exploring medi-
ation by an altered WM microstructure on cognitive func-
tioning would be appropriate.
Similar positive associations with the current study’s
diffusion metrics have been reported in previous studies
investigating adults within the general population. A study
by Ikram et al14 investigated the effect of MS risk variants
in adults on WM microstructure and found similar direc-
tions of effect (a higher FA and lower diffusivity) for their
top 5 most strongly associated risk variants when studying
these diffusion parameters, although these findings did not
survive multiple testing correction. A total of 110 non-
MHC risk variants were included, and the results may
have been affected by age-related brain changes. Brown
et al15 found similar results (also not significant) in adults
from the UK Biobank study when investigating associa-
tions between the PRS for MS and WM microstructure.
Again, these findings could have been affected by age-
related brain changes and the broad age range of partici-
pants who were included in the study. Our pediatric
cohort with a narrow age range minimizes the presence of
age-related differences; by using not only the genome-wide
significant variants in our genetic risk score, as done by
Ikram et al,14 we attempted to reflect the polygenic archi-
tecture of MS as much as possible.
The association between our MS PRS, which pre-
dominantly consists of immunological variants, and
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structural brain findings seems counterintuitive. Suscepti-
bility loci for MS are mainly expressed in different
immune cells, including T cells and B cells, and
microglia.9 Microglia in particular can affect oligodendro-
cyte functioning and myelination: through several inter-
leukin pathways (ie, IL-6 and IL-1β), microglia are able to
stimulate the survival and differentiation of oligodendro-
cyte precursor cells.42–45 Because enrichment of MS risk
variants has been shown in these pathways, oligodendro-
cytes and myelination could be influenced at a young age
through alternative regulation of microglia function, lead-
ing to a differing WM microstructure.9
Considering the large contribution several MHC risk
variants have in the genetic risk of MS, especially the class
II HLA genes (for example HLA-DPB1), we did not
exclude MHC risk variants in the PRS of MS.46 Sensitiv-
ity analyses excluding these variants show a decrease in the
magnitude of the effects, suggestive of a role of MHC risk
variants in the different microstructure of WM. This may
be driven by different MHC-related gene expression in
oligodendrocytes from individuals at a higher genetic risk
for MS, which has been found in experimental autoim-
mune encephalomyelitis, an animal model mimicking the
pathological process of MS.47
Taken together, individuals with a higher genetic
risk for MS may show altered WM development via an
interplay of altered immunological and oligodendrocyte
function. The counterintuitive direction of effect
(a positive relationship between MS PRS and FA, whereas
other studies show a negative association in adult and
pediatric MS patients) could indicate that environmental
risk factors for MS play an additional role in disease path-
ophysiology and its WM alterations. How these environ-
mental risk factors, such as smoking, vitamin D intake, or
infection with the Epstein–Barr virus, may add to this
process is unknown. Subsequently, how this altered WM
integrity in individuals with a higher MS risk leads to an
increased MS susceptibility remains elusive and yet to be
investigated.
There are several strengths to this study. First, we stud-
ied a large sample of children drawn from the general popu-
lation who underwent neuroimaging, giving us the
possibility of investigating subtle differences between the MS
PRS and the brain metrics. Second, all participants included
in this study were scanned on the same study-dedicated
MRI scanner, eliminating possible interscanner differences
from our main results. Third, our sample consisted of chil-
dren from a narrow age range, which can reduce age-related
influences in WM development. Fourth, we replicated the
findings in an independent group of children from the Gen-
eration R Study who were younger and scanned on a differ-
ent MRI system.
Our study also has limitations: the association
between the PRS for MS and imaging phenotypes was
tested in a cross-sectional study design, which precludes
measuring changes over time. We did not include the first
data collection wave of Generation R imaging participants
in the main results of our study because these individuals
were scanned on a different MRI system and encompassed
a smaller subgroup.18 Instead, we used these participants
as a replication sample to validate our results. Second,
higher maternal education was overrepresented in our study.
However, the height of the PRS was not affected by the level
of maternal education, and after performing an IPCW analy-
sis accounting for this overrepresentation of high maternal
education, the association between genetic risk for MS and
FA remained significant. Third, the GWAS for MS is rela-
tively less powered compared to other GWAS studies, such
as depression.48 This could lead to the low explained variance
we report, indicating a subtle effect. Increasing the sample
size of discovery GWAS studies can lead to an improved
accuracy and power of studied associations.
Future studies are needed to explore the observed
associations over time using a longitudinal study design.
Additional insight into the genetic overlap between WM
development and the pathophysiology of MS is also
needed. For example, in addition to the effect of common
variants, the association of rare MS risk variants with WM
microstructure could be explored to provide a more com-
plete understanding of disease pathogenesis.49 Further-
more, environmental risk factors of MS should be taken
into account, as these are partially modifiable, to investi-
gate the gene–environment interactions of MS and expand
our knowledge about MS pathophysiology. In conclusion,
we observed evidence that genetic risk for MS influences
brain development, in particular the WM microstructure,
in a pediatric population at an early age.
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